Paul Vermeersch

Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial

Daniel J.F.M. Thuijs, A. Pieter Kappetein, Patrick W. Serruys et al. · The Lancet · 2019 · 618 citations · Full text

Percutaneous Coronary Intervention, Controlled Syntax Trial, Endovascular Technique +8

Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug

Apostolos Tzikas, Samera Shakir, Sameer Gafoor et al. · EuroIntervention · 2016 · 539 citations

Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial

Michael Haude, Raimund Erbel, Paul Erné et al. · The Lancet · 2013 · 419 citations

Percutaneous Coronary Intervention, Engineering, De-novo Coronary Lesions +5

Increased Late Mortality After Sirolimus-Eluting Stents Versus Bare-Metal Stents in Diseased Saphenous Vein Grafts

Paul Vermeersch, Pierfrancesco Agostoni, Stefan Verheye et al. · Journal of the American College of Cardiology · 2007 · 265 citations

Endovascular Technique, Cardiovascular Disease, Vascular Surgery +8

Randomized Double-Blind Comparison of Sirolimus-Eluting Stent Versus Bare-Metal Stent Implantation in Diseased Saphenous Vein Grafts

Paul Vermeersch, Pierfrancesco Agostoni, Stefan Verheye et al. · Journal of the American College of Cardiology · 2006 · 257 citations

Endovascular Technique, Peripheral Intervention, Vascular Surgery +6